Pharmacology - 07:01
FDA grants Breakthrough Therapy Designation for Roche’s Gazyva (obinutuzumab) in Lupus Nephritis
FDA grants Breakthrough Therapy Designation for Roche’s Gazyva (obinutuzumab) in Lupus Nephritis
Pharmacology - Sep 17
Novartis Cosentyx positive 16-week PREVENT results advance potential new indication for patients with axial spondyloarthritis
Novartis Cosentyx positive 16-week PREVENT results advance potential new indication for patients with axial spondyloarthritis
Pharmacology - Sep 16
Roche receives FDA clearance for cobas pro integrated solutions designed to help labs deliver faster results to patients
Roche receives FDA clearance for cobas pro integrated solutions designed to help labs deliver faster results to patients
Pharmacology - Sep 13
Novartis Phase III ASCLEPIOS trials demonstrate robust efficacy of ofatumumab in patients with relapsing multiple sclerosis
Novartis Phase III ASCLEPIOS trials demonstrate robust efficacy of ofatumumab in patients with relapsing multiple sclerosis
Pharmacology - Sep 13
Roche presents new 6-year OCREVUS (ocrelizumab) data which showed that earlier initiation and continuation of treatment reduced disability progression in multiple sclerosis
Roche presents new 6-year OCREVUS (ocrelizumab) data which showed that earlier initiation and continuation of treatment reduced disability progression in multiple sclerosis
medicine and life sciences
Life Sciences - Sep 18
Health - Sep 18
Scientists at EPFL's Swiss Institute for Experimental Cancer Research have discovered a signaling pathway that breast tumors exploit to metastasize to the brain.
Pharmacology - Sep 18
Early combination treatment strategy with vildagliptin (Galvus ) and metformin was superior to standard of care in newly diagnosed type 2 diabetes patients , - The landmark VERIFY study is the first to investigate the long-term clinical benefits of this early combination strategy in type 2 diab
Selected Jobs
Chemistry - 18.09
Professor/in In-Vitro- und Molekulare Diagnostik (80–100 %) Fachhochschule Nordwestschweiz FHNW, Basel
Professor/in In-Vitro- und Molekulare Diagnostik (80–100 %) Fachhochschule Nordwestschweiz FHNW, Basel
Computer Science/Telecom - 10.09
Bioinformatician or Scientific Programmer at the Biomedical Sequencing Facility CeMM Research Center for Molecular Medicine, Vienna
Bioinformatician or Scientific Programmer at the Biomedical Sequencing Facility CeMM Research Center for Molecular Medicine, Vienna
Chemistry - 10.09
Synthetic organic chemist for targeted protein degradation (m/f/x) CeMM Research Center for Molecular Medicine, Vienna
Synthetic organic chemist for targeted protein degradation (m/f/x) CeMM Research Center for Molecular Medicine, Vienna
Pharmacology - 06.09
Wissenschaftliche/r Mitarbeitende/r Pharmazeutische Technologie (80%) ZHAW Zürcher Hochschule für Angewandte Wissenschaften, Wädenswil
Wissenschaftliche/r Mitarbeitende/r Pharmazeutische Technologie (80%) ZHAW Zürcher Hochschule für Angewandte Wissenschaften, Wädenswil
Life Sciences - 05.09
Research Associate Molecular Biology (100%) ZHAW Zürcher Hochschule für Angewandte Wissenschaften, Wädenswil
Research Associate Molecular Biology (100%) ZHAW Zürcher Hochschule für Angewandte Wissenschaften, Wädenswil
Employers of the Week
Continuing education for scientists and academics
»» 30.09.2019
CAS ETH in Räumliche Informationssysteme (CAS ETH RIS) Eidgenossische Technische Hochschule Zürich, ETHZ
CAS ETH in Räumliche Informationssysteme (CAS ETH RIS) Eidgenossische Technische Hochschule Zürich, ETHZ
»» 01.11.2019
MAS ETH in Applied Technology (MAS ETH AT) Eidgenossische Technische Hochschule Zürich, ETHZ
MAS ETH in Applied Technology (MAS ETH AT) Eidgenossische Technische Hochschule Zürich, ETHZ
»» 30.11.2019
CAS ETH in Mobilität der Zukunft: Neue Geschäftsmodelle Eidgenossische Technische Hochschule Zürich, ETHZ
CAS ETH in Mobilität der Zukunft: Neue Geschäftsmodelle Eidgenossische Technische Hochschule Zürich, ETHZ
Last job offers
- Mechanical Engineering - 18.9
Wissenschaftlicher Mitarbeiter/ Doktorand (m/w/d) „Direktmethanisierung von Wasserstoff in Biogasanlagen“ - Law/Forensics - 18.9
Wissenschaftlicher Mitarbeiter und Studiengangsmanager, (m/w), 60 % - Chemistry - 18.9
Professor/in In-Vitro- und Molekulare Diagnostik (80–100 %) - Media - 17.9
Doktorandin / Doktorand - Health - 17.9
Post-doctorant-e - Fonds National - Health - 17.9
Senior/Data Scientist CPS - Health - 17.9
Senior Scientist, Mucosal Immunology - Career - 17.9
Technician Training Experience (TTE)
Pharmacology - 07:01
FDA grants Breakthrough Therapy Designation for Roche’s Gazyva (obinutuzumab) in Lupus Nephritis
FDA grants Breakthrough Therapy Designation for Roche’s Gazyva (obinutuzumab) in Lupus Nephritis
Pharmacology - Sep 17
Novartis Cosentyx positive 16-week PREVENT results advance potential new indication for patients with axial spondyloarthritis
Novartis Cosentyx positive 16-week PREVENT results advance potential new indication for patients with axial spondyloarthritis
Pharmacology - Sep 16
Roche receives FDA clearance for cobas pro integrated solutions designed to help labs deliver faster results to patients
Roche receives FDA clearance for cobas pro integrated solutions designed to help labs deliver faster results to patients
Pharmacology - Sep 13
Novartis Phase III ASCLEPIOS trials demonstrate robust efficacy of ofatumumab in patients with relapsing multiple sclerosis
Novartis Phase III ASCLEPIOS trials demonstrate robust efficacy of ofatumumab in patients with relapsing multiple sclerosis
Pharmacology - Sep 13
Roche presents new 6-year OCREVUS (ocrelizumab) data which showed that earlier initiation and continuation of treatment reduced disability progression in multiple sclerosis
Roche presents new 6-year OCREVUS (ocrelizumab) data which showed that earlier initiation and continuation of treatment reduced disability progression in multiple sclerosis